Intellectual Property

  • March 11, 2025

    Software Co. Says Ex-Employees Stole AI Trade Secrets

    A software company that uses artificial intelligence to automate appeals when insurers deny a healthcare provider's payment request has sued two former staffers, alleging they used confidential information gathered through their employment to launch a competing company.

  • March 11, 2025

    Full Fed. Circ. Won't Rehear $95M Altria Patent Suit Win

    The Federal Circuit won't hold an en banc review of a $95 million judgment against R.J. Reynolds Vapor Co. that ended a suit from Altria Client Services LLC alleging that R.J. Reynolds infringed three of its patents.

  • March 11, 2025

    White House Names Ex-Goldman Sachs Atty To Lead USPTO

    U.S. President Donald Trump has nominated John Squires, Goldman Sachs' former longtime chief intellectual property counsel, to serve as the next U.S. Patent and Trademark Office director.

  • March 10, 2025

    Amgen, Fresenius Settle Osteoporosis Drug Patent Dispute

    Amgen Inc. and Fresenius Kabi USA have reached an agreement resolving Amgen's allegations that Fresenius infringed a long list of patents covering drugs for treating osteoporosis and preventing bone problems, according to an order issued Friday in New Jersey federal court.

  • March 10, 2025

    Meta Can't Ditch Authors' Copyright Claim In AI Tool Fight

    A California federal judge has refused to throw out group of authors' claim that Meta Platforms Inc. violated the Digital Millennium Copyright Act claim with its large language model product, ruling that they've adequately alleged that Meta intentionally removed copyright notice information to conceal infringement.

  • March 10, 2025

    Nike Receives $355K From Lululemon In Shoe Patent Trial

    A New York federal jury has found that athletic apparel maker Lululemon infringed one Nike footwear manufacturing patent but did not infringe a second, and awarded Nike $355,450 in damages, well below the $2.8 million the shoe giant was seeking.

  • March 10, 2025

    Realtek's Antitrust Claims Against MediaTek Pared Back

    A California federal judge on Friday dismissed Realtek Semiconductor's claims that MediaTek and two other companies conspired to restrain trade through a series of sham patent suits, while keeping claims tied to two 2021 federal cases in Texas that he said Realtek plausibly alleged to be baseless.

  • March 10, 2025

    Fed. Circ. Vacates PTAB Decision Partly Axing 4G Patent

    The Federal Circuit on Monday vacated a Patent Trial and Appeal Board decision partly invalidating a Sisvel patent that the company says is essential to the 4G standard and has asserted against other businesses in infringement litigation.

  • March 10, 2025

    Alsup Refuses To Vacate Hearing Into OPM Mass Firings

    U.S. District Judge William Alsup on Monday denied the Trump administration's request to vacate an upcoming evidentiary hearing into the U.S. Office of Personnel Management's mass firings of probationary federal employees, and required OPM director Charles Ezell to appear in person or else be deposed.

  • March 10, 2025

    Ga. IP Boutique Says Md. Firm Copied Its 'Founders' Mark

    A Georgia-based law firm that does business as Founders Legal on Monday sued a similarly named Maryland firm and its founder for allegedly infringing its federally registered marks in a way that is likely to confuse prospective and current legal clients.

  • March 10, 2025

    Patent Office Solicitor Moves To PTAB Vice Chief Judge Role

    Farheena Y. Rasheed, who had been the U.S. Patent and Trademark Office's solicitor since June, has moved to a new role as a Patent Trial and Appeal Board acting vice chief judge, to assist the board as it deals with several vacancies, the office said Monday.

  • March 10, 2025

    DOJ Wants In On Invisalign Monopoly Arguments At 9th Circ.

    The U.S. Department of Justice wants to be there when orthodontists and consumers who purchased clear teeth aligners face off with the company behind Invisalign at the Ninth Circuit next month, so it can tell the appellate judges where the lower court went wrong in killing their monopoly suits.

  • March 10, 2025

    Miley Cyrus Says 'Glee' Ruling Wilts 'Flowers' Copyright Suit

    An attorney for Miley Cyrus and co-writers of her hit "Flowers" urged a California federal judge Monday to toss a music investment company's complaint alleging they ripped off a Bruno Mars song, arguing that a Ninth Circuit ruling clearing the school that inspired the show "Glee" of infringement supports the move.

  • March 10, 2025

    Adidas Seeks Injunction In Fashion Nova Trademark Row

    Adidas is seeking a preliminary injunction against Fashion Nova, accusing the popular fast-fashion brand in a California federal lawsuit of infringing on its iconic three-stripe trademark and noting that the company has "a penchant for overlooking" intellectual property rights.

  • March 10, 2025

    Money Manager Can't Block Alleged Client Poach, Judge Says

    Connecticut investment firm TJT Capital Group LLC has not demonstrated that it will suffer irreparable harm without a temporary restraining order that bars a former member from using client information he allegedly misappropriated, a federal judge has ruled in denying the request.

  • March 10, 2025

    Disney Unit Wins Copyright Trial Over 'Moana' Film

    A Los Angeles federal jury handed a win Monday to a subsidiary of The Walt Disney Co. in a copyright infringement trial over the 2016 blockbuster "Moana," rejecting a claim that the movie ripped off another animation artist's Polynesian adventure epic.

  • March 10, 2025

    Fed. Circ. Skeptical Of USPTO's Refusal To Register F-Word TM

    A Federal Circuit panel appeared skeptical of the U.S. Patent and Trademark Office's reasoning for rejecting an application to register the F-word as a mark because of its widespread use, with one judge telling the government's attorney a couple of times during arguments Monday, "I don't understand what you're saying."

  • March 10, 2025

    Perkins Coie Adds 2 Finnegan IP Attys In Calif.

    Perkins Coie LLP is growing its West Coast team, announcing Monday it is bringing in two Finnegan Henderson Farabow Garrett & Dunner LLP intellectual property attorneys as partners in its Silicon Valley office in Palo Alto, California.

  • March 10, 2025

    Patent Exec Seeks Defamation Win Over Atty's Statements

    A patent-licensing company executive has asked a Florida federal court to rule in his favor on a defamation claim against a Baker Botts LLP attorney representing Starbucks in a Texas patent case and toss a counterclaim from the attorney, saying her abuse-of-process allegation "reads like a failed exercise in ontological gymnastics."

  • March 10, 2025

    CBD Co. Launches More Patent Suits Over Topical Cream

    CBD company Metronome LLC has filed another pair of suits in Delaware federal court alleging competitors are infringing its patent with a topical pain relief cream that uses cannabis-derived ingredients.

  • March 10, 2025

    Philly Inquirer Cuts IP Deal With Framed Front Page Seller

    The Philadelphia Inquirer has confidentially settled its infringement suit against a company that sold framed copies of its articles and front pages, according to filings in Pennsylvania federal court.

  • March 10, 2025

    Fed. Circ. Won't Pause Teva Patent Delisting For Appeal

    The Federal Circuit denied on Friday Israeli drugmaker Teva Pharmaceuticals' bid to keep an injunction ordering it to remove its inhaler patents from the U.S. Food and Drug Administration's Orange Book on hold pending its appeal of the matter to the U.S. Supreme Court.

  • March 10, 2025

    High Court Skips Florida Brokerage's Copyright Fee Appeal

    The U.S. Supreme Court on Monday declined to review a Florida real estate brokerage firm's challenge to lower court decisions denying it attorney fees when another company accusing it of copyright infringement voluntarily dropped the case.

  • March 07, 2025

    FDA Can Take Eli Lilly Weight Loss Drug Off Shortage List

    A Texas federal judge has refused to issue an injunction that would allow compounding pharmacies to produce a lucrative weight loss drug, ruling that the U.S. Food and Drug Administration was within its authority when it removed the medication from the drug shortage list.

  • March 07, 2025

    Photographer Sanctioned For Skipping Deposition In IP Case

    A federal judge in the Southern District of New York has issued sanctions over skipped depositions, among other conduct, by the plaintiff in a copyright lawsuit over a photo of actor Jonah Hill that appeared on a fashion retail website. 

Expert Analysis

  • Notable 2024 Trademark Cases And What To Watch In 2025

    Author Photo

    Emerging disputes between established tech giants and smaller trademark holders promise to test the boundaries of trademark protection in 2025, following a 2024 marked with disputes in areas ranging from cybersquatting to geographic marks, says Danner Kline at Bradley Arant.

  • How A 9th Circ. Identicality Ruling Could Affect AI Cos.

    Author Photo

    If the Ninth Circuit agrees to settle a district court split over whether the Digital Millennium Copyright Act requires a copy to be identical to an original to support an actionable claim for removing copyright management information, the decision could have important ramifications for artificial intelligence businesses, says Maria Sinatra at Venable.

  • The State Of USPTO Rulemaking At The End Of Vidal's Term

    Author Photo

    As U.S. Patent and Trademark Office director, Kathi Vidal placed a particular emphasis on formal rulemaking — so as she returns to private practice this week, attorneys at Irell take stock of which of her proposals made it across the finish line, and where the rest stand on the cusp of a new administration.

  • Examining Vidal's Guidance On PTAB Section 315 Time Bar

    Author Photo

    Last month's decision by outgoing U.S. Patent and Trademark Office Director Kathi Vidal in Luminex v. Signify addresses the Section 315 statutes that preclude institution of inter partes review proceedings after certain civil actions are filed, and is instructive as PTAB panels are likely to follow this approach going forward, says Amanda Wieker at McGuireWoods.

  • What A Motorcycle IP Case Says About Parallel Int'l Litigation

    Author Photo

    A Texas federal court recently rejected an electric motorcycle manufacturer's attempt to dismiss a design patent suit in the U.S. and limit the litigation to China, illustrating the challenges in trying to counter a parallel litigation strategy, say attorneys at King & Wood.

  • What 2024 Trends In Marketing, Comms Hiring Mean For 2025

    Author Photo

    The state of hiring in legal industry marketing, business development and communications over the past 12 months was marked by a number of trends — from changes in the C-suite to lateral move challenges — providing clues for what’s to come in the year ahead, says Ben Curle at Ambition.

  • Navigating The Minefield Of Patenting AI-Generated Inventions

    Author Photo

    For businesses and individuals trying to patent inventions partially developed with assistance from artificial intelligence — like software that's been coded by AI — recordkeeping and diligent documentation are of paramount importance when seeking patent protection, says Robert Plotkin at Blueshift IP.

  • How Attorneys Can Master The Art Of Eye Contact At Trial

    Author Photo

    As a growing body of research confirms that eye contact facilitates communication and influences others, attorneys should follow a few pointers to maximize the power of eye contact during voir dire, witness preparation, direct examination and cross-examination, says trial consultant Noelle Nelson.

  • Series

    Group Running Makes Me A Better Lawyer

    Author Photo

    The combination of physical fitness and community connection derived from running with a group of business leaders has, among other things, helped me to stay grounded, improve my communication skills, and develop a deeper empathy for clients and colleagues, says Jessica Shpall Rosen at Greenwald Doherty.

  • 7th Circ. Ruling Muddies Split On Trade Secret Damages

    Author Photo

    The Seventh Circuit's recent endorsement in Motorola v. Hytera of a Second Circuit limit on avoided-cost damages under the Defend Trade Secrets Act contradicts even its own precedents, and will further confuse the scope of a developing circuit conflict that the U.S. Supreme Court has already twice declined to resolve, says Jordan Rice at MoloLamken.

  • Opinion

    6 Changes I Would Make If I Ran A Law School

    Author Photo

    Reuben Guttman at Guttman Buschner identifies several key issues plaguing law schools and discusses potential solutions, such as opting out of the rankings game and mandating courses in basic writing skills.

  • Nutraceutical Patent Insights As Market Heats Up

    Author Photo

    Companies entering the expanding nutraceutical market and seeking patents to protect their innovations should evaluate successful nutraceutical claim language and common patent challenges in this field, say attorneys at Sterne Kessler.

  • Firms Still Have The Edge In Lateral Hiring, But Buyer Beware

    Author Photo

    Partner mobility data suggests that the third quarter of this year continued to be a buyer’s market, with the average candidate demanding less compensation for a larger book of business — but moving into the fourth quarter, firms should slow down their hiring process to minimize risks, say officers at Decipher Investigative Intelligence.

  • Nintendo Suit May Have Major Impact On Video Game Patents

    Author Photo

    If Nintendo and The Pokémon Co. win their patent infringement case in Japan against Pocketpair, the game developer behind Palworld, it could pose new challenges for independent game creators — but it could also encourage innovation, says Charles Morris at Marshall Gerstein.

  • Teaching Your Witness To Beat The Freeze/Appease Response

    Author Photo

    In addition to fight-or-flight, witnesses may experience the freeze/appease response at trial or deposition — where they become a deer in headlights, agreeing with opposing counsel’s questions and damaging their credibility in the process — but certain strategies can help, says Bill Kanasky at Courtroom Sciences.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!